CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Top of the Street: GSK, Campari, Bridgepoint Group

By Reuters News

A round-up of notable broker activity this morning from Europe's top-ranked* analysts:

** Jefferies cuts British drugmaker GSK GSK.L to "hold" from "buy," citing weaker earnings momentum, launch execution risks and fewer key pipeline catalysts

** Equita cuts Italian spirits group Campari CPRI.MI to "hold" from "buy", citing a tougher US context and a need for more visibility on portfolio stabilization

** BofA raises British private equity group Bridgepoint Group BPTB.L to "buy" from "neutral," citing undervalued shares and stronger earnings growth prospects

(*Analyst rankings from Thomson Reuters StarMine. The scale is from 1-star to 5-star with 5 being the best. Analysts are ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk